European Society of Gene & Cell Therapy-17th Annual Congress
(2010) I Drugs: The Investigational Drugs Journal — Vol. 13, n° 2, p. 63-65 (2010)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- The 17th Annual Congress of the European Society of Gene & Cell Therapy, held in Hanover, Germany, included topics covering new developments in the field of stem cell therapy. This conference report highlights selected presentations on stem cell gene therapy and the use of stem cells in regenerative medicine. Investigational therapies discussed include Lenti-D (Genetix Pharmaceuticals Inc/INSERM) and LentiGlobin (Genetix), a lentiviral vector-based gene transfer system containing either a human beta-globin gene or a hybrid A-gamma/beta-globin gene.
- Affiliations
Citations
Chuah, M. (2010). European Society of Gene & Cell Therapy-17th Annual Congress. I Drugs: The Investigational Drugs Journal, 13(2), 63-65. https://hdl.handle.net/2078.5/76243 (Original work published 2010)